Abrdn Healthcare Investors
NYSE:HQHAsset Management
+$0.15 today
- Market cap
- $1.27B
- Beta
- 0.76
- P/E (TTM)
- 4.2
- EPS (TTM)
- $4.72
- Dividend yield
- 11.57%
Volume 0.23M
Average 0.14M
HQH Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Abrdn Healthcare InvestorsNYSE: HQH
Cash & Equivalents · Q4 FY2025 · quarter ended Sep 2025
Cash & equivalents of $59 in Q4 FY2025
Q4 FY2025 cash & equivalents was $59. Over 3 fiscal years it compounded at -57.9% a year.
Context
- Cash & equivalents amounted to 0.0% of total assets at the end of Q4 FY2025.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 59 USD
- Year-over-year change
- +5.4%
- 4-year CAGR
- -49.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 59 | +5.4% |
| FY2024 | 2024-12-31 | 56 | -73.8% |
| FY2023 | 2023-12-31 | 214 | -73.0% |
| FY2022 | 2022-12-31 | 792 | -15.3% |
| FY2021 | 2021-12-31 | 935 | — |
Cash & Equivalents vs competitors
How HQH compares with its peers on the latest reported figures
- HQH's Sep 2025 cash & equivalents of $59 is the lowest of the 10 companies compared; the peer median is $42.63M.
- Cash & equivalents amounts to 0.0% of total assets for HQH, versus a peer median of 2.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $136.64M | -37.6% | -6.8% | 3.0% | |
| Mar 2026 | $121.87M | +9.4% | +33.6% | 4.4% | |
| Mar 2026 | $68.46M | -53.3% | +40.9% | 2.7% | |
| Mar 2026 | $51.13M | -40.2% | +4.3% | 2.1% | |
| Mar 2026 | $42.63M | -49.9% | +4.5% | 1.4% | |
| Mar 2026 | $34.49M | +4.4% | +72.3% | 4.4% | |
| Mar 2026 | $30.57M | -20.3% | -0.5% | 1.2% | |
| Mar 2026 | $19.63M | +134.1% | +21.7% | 0.8% | |
KBDCKayne Anderson BDC, Inc. | Mar 2026 | $14.31M | -17.6% | +28.3% | 0.6% |
| Sep 2025 | $59 | — | -57.9% | 0.0% | |
| Peer median (excluding HQH) | $42.63M | -20.3% | +21.7% | 2.1% | |
Competitors are the stored peer set for HQH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Abrdn Healthcare Investors
NYSE:HQH
Intrinsic Alpha fair value
Locked
Current Price
$22.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.